Compare Marathon Petroleum Corp (MPC) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marathon Petroleum Corp vs Novartis AG — how do they compare? Marathon Petroleum Corp trades at $318.36 (market cap $92.05B), while Novartis AG trades at $153.88 (market cap $290.25B). The key difference: Novartis AG is far larger — about 3.2× Marathon Petroleum Corp's market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| MPC | NVS | |
|---|---|---|
Market Cap | $92.05B | $290.25B |
Sector | Energy | Health |
52-Week High | $315.31 | $168.62 |
52-Week Low | $158.59 | $113.50 |
Enterprise Value | $124.23B | $330.27B |
Dividend Yield | 1.24% | 3.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Marathon Petroleum (MPC) trades at $319.76, up 2.29% with strong technical momentum and bullish moving average signals. The stock shows robust fundamentals with a 27.92% ROE and 3.42% net margin, though revenue has declined from $177.5B in 2022 to $132.7B in 2025. Recent earnings beat expectations in Q4 2025 and Q1 2026, while analyst consensus remains strongly bullish with 25 buy ratings and a $292.70 price target. The company benefits from strong refining margins and strategic upgrades driving profitability.
MPC presents a compelling investment case with strong profitability metrics and positive analyst sentiment, though investors should monitor declining revenue trends and elevated debt levels. The stock's current price near resistance levels suggests potential for consolidation, while refining margin advantages and limited Russian capacity create tailwinds. Key risks include oil price volatility and macroeconomic pressures on energy demand.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Marathon Petroleum Corp
Marathon Petroleum is an independent refiner with 13 refineries in the midcontinent, West Coast, and Gulf Coast of the United States with total throughput capacity of 2.9 million barrels per day. Its Dickinson, ND, facility produces 184 million gallons a year of renewable diesel. Its Martinez, CA, facility will have the ability to produce 730 million gallons a year of renewable diesel once converted. The firm also owns and operates midstream assets primarily through its listed MLP, MPLX.
Read more on MPC →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
